Taejon, South Korea

Se Ho Park

This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Corporation. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Se Ho Park. Retrieved from https://idiyas.com/inventor/se-ho-park-plvx1rrg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Se Ho Park: Innovator in Antimicrobial Peptide Production

Introduction

Se Ho Park is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of antimicrobial peptides. His innovative work has the potential to impact various industries, including healthcare and agriculture.

Latest Patents

Se Ho Park holds a patent for a "Mass production method of antimicrobial peptide and DNA construct and expression system thereof." This invention relates to DNA constructs that enable the efficient production of antimicrobial materials from microorganisms. The patent outlines a method that includes preparing an expression vector containing a DNA construct, transforming bacterial host cells, culturing the transformed cells, and recovering the antimicrobial peptide.

Career Highlights

Park is associated with Samyang Genex Corporation, where he applies his expertise in biotechnology. His work focuses on developing methods that enhance the production of antimicrobial peptides, which are crucial for combating microbial infections.

Collaborations

Se Ho Park collaborates with talented individuals such as Jeong Hyun Kim and Min Hyung Kang. Their combined efforts contribute to advancing research and development in the field of antimicrobial peptides.

Conclusion

Se Ho Park's innovative approach to mass-producing antimicrobial peptides showcases his commitment to advancing biotechnology. His contributions are poised to make a significant impact in various applications, enhancing the fight against microbial threats.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…